Abstracts de Psiquiatría
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe
The Lancet Psychiatry Fecha de publicación: 1 de enero de 2022 Autores: Dragana Bugarski-Kirola, MD , Prof Celso Arango, MD, Prof...
Association of school absence and exclusion with recorded neurodevelopmental disorders, mental disorders, or self-harm: a nationwide, retrospective, electronic cohort study...
Lancet Psychiatry Fecha de publicación: 1 de enero de 2022 DOI: https://doi.org/10.1016/S2215-0366(21)00367-9 Autores: Prof Ann John, MD , Yasmin Friedmann, PhD,...
Anxiety disorders and age-related changes in physiology
British Journal of Psychiatry Fecha de publicación: 6 de enero de 2022 Autores: Julian Mutz, Thole H. Hoppen, Chiara Fabbri...
Predicting relapse or recurrence of depression: systematic review of prognostic models
British Journal of Psychiatry Fecha de publicación: 11 de enero de 2022 Autores: Andrew S. Moriarty ,Nicholas Meader, Kym I....
Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts
American Journal of Psychiatry Fecha de publicación: 14 de mayo de 2021 Autores: Travis T. Mallard, M.A., Jeanne E. Savage, Ph.D., Emma C. Johnson, Ph.D., Yuye...
Lo más popular
Predicting relapse or recurrence of depression: systematic review of prognostic models 
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffect... 
Uncovering the realities of delusional experience in schizophrenia: a qualitative phenomen... 
The prevalence of personality disorders in the community: a global systematic review and m... 
Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first... 
Schizophrenia risk alleles and neurodevelopmental outcomes in childhood: a population-base... 
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Cont...